tirzepatide 10mg/0.5ml 10mg They contain the active ingredient tirzepatide Tirzepatide Injectable – 10 mg/mL

Read more about it here: #GLP1 To view or add a comment, sign in Earlier this month the FDA announced the establishment of a "green list" import alert for GLP-1s designed to prevent unverified GLP-1 active pharmaceutical ingredients from entering the United States

Symptoms following acute NSAID overdose are usually limited to lethargy, drowsiness, nausea, vomiting and epigastric pain, gastrointestinal bleeding can occur but very rarely, hypertension, acute renal failure, respiratory depression and coma

The dosage is gradually increased over time to minimize side effects like nausea, which is one of the most common initial reactions

Early Phase 2 data showed a projected weight loss of up to 25% at 68 weeks

Behavior Change Group Better Maintains Weight Loss 11 11 6 out of 7 people stop taking GLP-1s 12